What to Know About Spravato

How can Spravato (esketamine) benefit me?

Spravato (esketamine) may be helpful for you because it works differently than traditional antidepressants, targeting neural pathways involved in mood regulation, flexibility, and stress response rather than relying solely on daily serotonin modulation. For individuals who continue to experience depressive symptoms despite other treatments, Spravato can offer more rapid relief by helping the brain form new connections and loosen entrenched patterns of negative thinking. Under medical supervision, it may support improved mood, increased emotional responsiveness, and a greater sense of mental spaciousness—making it easier to engage in therapy and daily life while other treatments continue to do their work.

Next Steps to Begin Spravato Treatment

Esketamine (Spravato) vs. Ketamine
Spravato is a good choice when you need to use medical insurance to pay for treatment.

If you’re wondering whether Spravato could be a good fit for you, the next step is a consultation. A brief, confidential conversation can help clarify your symptoms, treatment history, and goals, and determine whether this approach makes sense for your care. Reach out to schedule a consult and get clear, thoughtful guidance on your options.

gET A CONSULT ABOUT SPRAVATO

How Spravato Treatment Works

Spravato for treatment-resistant depression

Before starting Spravato (esketamine), you’ll go through a careful qualification process to determine whether it’s an appropriate and safe option for you. This includes a clinical evaluation of your symptoms, mental health history, prior medication trials, and overall medical profile. Spravato is typically considered for adults with treatment-resistant depression or depression with acute suicidal ideation, and it must be prescribed and administered by a certified provider in a monitored clinical setting.

If you qualify, dosing follows a structured protocol. Spravato is self-administered as a nasal spray during supervised clinic visits, with monitoring afterward to ensure safety and tolerability. Treatment usually begins with an induction phase, involving two sessions per week for several weeks, followed by a maintenance phase in which dosing frequency is gradually reduced based on your response and clinical needs. The dose itself may be adjusted over time, guided by symptom improvement, side effects, and how your body responds. Throughout the process, care is collaborative and closely monitored, with the goal of finding the lowest effective dose that supports meaningful improvement.

gET A CONSULT ABOUT SPRAVATO

Spravato: The “Anti–Antidepressant” Changing the Direction of Psychiatry

young woman wearing hat

For decades, the treatment of depression followed a familiar script: prescribe an antidepressant, wait several weeks, and hope for gradual relief. For many patients, this model works. But for millions living with treatment-resistant depression—those who have tried multiple medications without success—the system has often felt slow, frustrating, and, at times, hopeless.

The introduction of Spravato marks a meaningful shift in that narrative.

Approved by the FDA in 2019, Spravato is derived from ketamine and represents one of the first fundamentally new approaches to depression in decades. Unlike traditional antidepressants, which primarily target serotonin, norepinephrine, or dopamine, Spravato works on the brain’s glutamate system—thought to play a key role in neuroplasticity, or the brain’s ability to adapt and form new connections.

Time magazine famously referred to ketamine-based treatments as the “anti–antidepressant,” highlighting how quickly they can act compared to conventional medications. While traditional antidepressants may take weeks to show benefit, some patients receiving Spravato report meaningful symptom relief within hours to days. For individuals caught in the weight of severe depression, that shift in timeline can be life-changing.

It’s important to be precise here: Spravato is not a universal solution, and it is not necessarily “more effective” for every patient than every antidepressant. But for those who haven’t responded to standard treatments, it offers something that previously didn’t exist—a new mechanism, a new pathway, and, often, a renewed sense of possibility.

A Different Kind of Experience

Treatment with Spravato also looks different from a typical psychiatric appointment. Administered as a nasal spray in a medical setting, each session includes a period of observation, allowing clinicians to monitor both safety and response.

Patients remain awake, often describing a temporary altered state—ranging from mild detachment to a more introspective, reflective experience. This is not considered a side effect to be eliminated, but part of what makes the treatment distinct.

A Patient’s Perspective

“I had tried everything,” one patient shared. “Medication after medication. Therapy. Nothing really touched it.” After beginning Spravato treatment, the shift was subtle at first.

“It wasn’t like I suddenly felt happy. It was more like the heaviness started to lift. For the first time in a long time, I felt like I could actually move—like I had space in my mind again.” Over the following weeks, that initial shift deepened.

“It gave me a foothold. Something I could actually build on in therapy. Before, everything felt stuck.”

Where Psychiatry Is Headed

Spravato is not just a new medication; it reflects a broader evolution in how psychiatry understands and treats depression. Rather than focusing solely on correcting chemical imbalances, newer approaches are exploring how to restore flexibility, resilience, and connection within the brain.

For patients who have felt left behind by traditional treatments, that evolution matters.

Because sometimes the breakthrough isn’t just a better version of what already exists.

Sometimes, it’s something entirely different.

Spravato can temporarily affect blood pressure, coordination, and awareness. The required observation period ensures you’re medically stable and fully recovered before leaving. It’s a safety protocol mandated by the FDA’s REMS program.

Yes, and in fact, Spravato is typically prescribed alongside an oral antidepressant, not as a standalone treatment. Your provider will coordinate your medications to ensure safety and effectiveness.

Spravato dosing follows a structured protocol (induction → maintenance). While some patients require adjustments, the goal is to find the lowest effective frequency—not to continuously increase dose.

No. You’ll need a ride home and should plan to rest for the remainder of the day. Most patients return to normal activities the following day.

Not necessarily. Some patients have a noticeable subjective experience, while others feel minimal effects. Clinical improvement is measured over time—not by how intense the session feels.

Spravato is generally shorter-acting and more standardized in dosing. Some patients find it less intense than IV ketamine, though experiences vary. The clinical benefit is not dependent on intensity.

We typically recommend avoiding food for about 2 hours and liquids for 30 minutes before your session to reduce the chance of nausea.

Consistency matters, especially during the initial phase. If you miss a session, we’ll adjust your schedule to keep your treatment on track without restarting unnecessarily.

Spravato is a controlled substance, but when used in a supervised medical setting with structured dosing, the risk of misuse is low. Ongoing monitoring is part of the treatment process.

Both are okay. Some patients prefer to relax quietly with music or an eye mask; others may want light conversation. We’ll support whatever helps you feel most comfortable.

Not necessarily. Many patients transition to less frequent maintenance or discontinue after sustained improvement. The goal is long-term stability, not indefinite treatment.